SynthesisJournal of medical Internet research2025
Mobile Phone Messaging-Based Interventions to Improve Physical Activity in Patients With Cancer: Systematic Review and Meta-Analysis.
Synthesis in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite the benefits of physical activity (PA) for improving cancer-related outcomes, the majority of patients with cancer fail to meet PA guidelines. Mobile phone messaging is a scalable approach for promoting PA, but its effect on improving PA among patients with cancer has not been reviewed. Objective: This review aims to systematically evaluate the effects of mobile phone messaging-based interventions in promoting PA among patients with cancer. Methods: A systematic search in 8 English and Chinese databases (PubMed, EMBASE, Web of Science, MEDLINE, the Cochrane Library, Scopus, Wanfang, and China National Knowledge Infrastructure) was performed. Randomized controlled trials that examined the effect of mobile phone messaging-based interventions on improving PA among patients with cancer were included. Potential sources of substantial heterogeneity were investigated by subgroup analysis based on participants' characteristics, mobile phone messaging regimens, and PA estimates. Random effects models were used to estimate the overall effect size. Risk of bias was assessed by 2 independent reviewers using the revised Cochrane Collaboration's risk of bias tool. Sensitivity analyses were performed through leave-one-out analyses, removal of outliers, and inclusion of only studies with low or some risk of bias. Potential publication bias was explored. Results: A total of 13 studies involving 777 individuals were included in this review. After intervention, mobile phone messaging-based interventions significantly improved objective PA with a small effect size (standardized mean difference [SMD]=0.37, 95% CI 0.10-0.64; P=.007; I2=0%), but not self-reported PA (SMD=0.20, 95% CI -0.07 to 0.47; P=.15; I2=56%) or step count (SMD=0.27, 95% CI -0.19 to 0.73; P=.25; I2=69%). Interventions that adopted more behavior change techniques and targeted patients who have completed active cancer treatment significantly improved step count. At follow-up, the effect of mobile phone messaging on self-reported PA, objective PA, and step count was found to be insignificant. Nine studies showed low or some risk of bias. Sensitivity analyses and trim-and-fill tests confirmed relatively stable effects of mobile phone messaging. No potential publication bias was identified. Conclusions: Mobile phone messaging-based interventions show promise as a scalable intervention to modestly improve objective PA in patients with cancer, though effects vary, with limited impact on self-reported PA or step count. Evidence for sustained long-term benefit remains limited, highlighting the need for rigorously designed trials with extended follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.